Drug Trials Snapshots: YORVIPATH (palopegteriparatide) injection

YORVIPATH is a parathyroid hormone analog that is approved for the treatment of hypoparathyroidism in adults. Hypoparathyroidism is a disease in which there is insufficient parathyroid hormone (PTH) production, which leads to hypocalcemia (blood calcium levels that are low). https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-yorvipath